Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Genocea Biosciences (GNCA) - Total debt
Total debt on the balance sheet as of March 2022 : $15.48 M
According to Genocea Biosciences 's latest financial reports the company's total debt is $15.48 M. A company’s total debt is the sum of all current and non-current debts.
Genocea Biosciences - Total debt on balance sheet (from 2012 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | $17.18 M | -28.02% |
| 2020-12-31 | $23.87 M | 19.86% |
| 2019-12-31 | $19.91 M | 34.39% |
| 2018-12-31 | $14.82 M | 3.57% |
| 2017-12-31 | $14.31 M | -15.61% |
| 2016-12-31 | $16.95 M | 2.92% |
| 2015-12-31 | $16.47 M | 43.43% |
| 2014-12-31 | $11.48 M | 17.3% |
| 2013-12-31 | $9.79 M | 142.13% |
| 2012-12-31 | $4.04 M | 1873.17% |
| 2011-12-31 | $0.2 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 457,407.27% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 226,280.37% | 🇺🇸 USA |
 Novavax NVAX | $0.22 B | 1,379.37% | 🇺🇸 USA |
 Agenus
AGEN | $78.01 M | 403.79% | 🇺🇸 USA |
 iBio IBIO | $16.46 M | 6.35% | 🇺🇸 USA |